Genericart Metoprolol Succinate 50mg Tablet ER contains Metoprolol Succinate 47.5mg, an extended-release beta-1 selective adrenergic receptor blocker used primarily in the management of hypertension, angina pectoris, and heart failure. By selectively inhibiting beta-1 receptors in cardiac tissue, it reduces heart rate, myocardial contractility, and cardiac output, thereby decreasing oxygen demand and lowering blood pressure. This medication is indicated for the treatment of high blood pressure to reduce the risk of stroke, heart attack, and kidney problems. It is also prescribed for the management of stable angina and to improve survival following myocardial infarction. The extended-release formulation allows for once-daily dosing, promoting better patient compliance and stable plasma drug concentrations. Genericart Metoprolol Succinate should be administered with caution in patients with bradycardia, heart block greater than first degree, or severe peripheral arterial disease. Dose adjustments may be necessary in patients with hepatic impairment. Common side effects include fatigue, dizziness, and gastrointestinal disturbances. Abrupt discontinuation should be avoided to prevent exacerbation of angina or precipitating myocardial infarction. Regular monitoring of blood pressure and heart rate is recommended during therapy to ensure optimal therapeutic outcomes.